Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Emerging Role of Serum IGF-I/IGFBP-3 Ratio in the Diagnosis of Children With Growth Hormone Deficiency

NCT02424240 is registered in ClinicalTrials.gov with University of Jordan as lead sponsor.

NCT NCT02424240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02424240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Emerging Role of Serum IGF-I/IGFBP-3 Ratio in the Diagnosis of Children With Growth Hormone Deficiency
Lead sponsor
University of Jordan
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
Not reported
Enrollment
134 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis of ghd with igf-i/igfbp-3 ratio